Cargando…
Evaluation of serum endocan levels in relation to epicardial fat tissue thickness in metabolic syndrome patients
INTRODUCTION: Metabolic syndrome has been recognized as a predictor of cardiovascular diseases. Epicardial fat tissue (EFT) thickness has recently been shown to be a predictor of cardiovascular diseases in metabolic syndrome patients. Endocan is a novel molecule which is considered to be an early ma...
Autores principales: | Boyuk, Banu, Cetin, Seher Irem, Erman, Hande, Sevinc, Samet, Bulut, Umit, Guzel, Savas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885812/ https://www.ncbi.nlm.nih.gov/pubmed/33644488 http://dx.doi.org/10.5114/amsad.2020.103031 |
Ejemplares similares
-
Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome
por: Erman, Hande, et al.
Publicado: (2020) -
Evaluation of subclinical cardiovascular disease by carotid intima media thickness, epicardial adipose tissue thickness, serum endocan, and nesfatin-1 levels in patients with primary hyperparathyroidism
por: KOCABAŞ, Muhammet, et al.
Publicado: (2022) -
Epicardial fat thickness is associated with retinopathy in patients with newly diagnosed hypertension
por: Ozer, Savas, et al.
Publicado: (2021) -
Relationship between Metabolic Syndrome Components and COVID-19 Disease Severity in Hospitalized Patients: A Pilot Study
por: Erman, Hande, et al.
Publicado: (2022) -
Factors related to the presence of nonalcoholic fatty liver disease in patients with type 2 diabetes: a single center study
por: Akin, Seydahmet, et al.
Publicado: (2023)